Lv1
30 积分 2022-05-09 加入
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma
19小时前
待确认
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
20小时前
已完结
Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance
3个月前
已完结
Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis
3个月前
已关闭
Targeting Solid Tumors Using CD3 Bispecific Antibodies
3个月前
已完结
Hyperprogressive disease: recognizing a novel pattern to improve patient management
3个月前
已完结
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
4个月前
已完结
Nanotheranostic Strategies for Cancer Immunotherapy
4个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
4个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
4个月前
已完结
皖公网安备34019202002308
